Silo Pharma to Acquire Exclusive Licensing for Alzheimer’s Therapeutic from Columbia University April 10, 2024
Silo Pharma Reports Positive Results for SP-26 Ketamine Implant in Pre-Clinical Study February 14, 2024
Silo Pharma Gets Green Light to Start Development of Ketamine Implant for Pain Relief December 29, 2023